Knowledge Ecology International (KEI) comments
U.S. House of Representatives, Committee on Ways and Means, Subcommittee on Trade, March 13, 2013 Hearing on U.S.-India Trade Relations
Name: James Love
Organization: Knowledge Ecology International
Address: 1621 Connecticut Avenue NW, Suite 500, Washington, DC 20009
Phone Number: 1.202.332.2670
Contact E-mail Address: James.Love@KEIonline.Org
Title of Hearing: U.S.-India Trade Relations
Introduction
Continue Reading →
On Monday, March 18, 2013, the National Institutes of Health (NIH), held a conference call with the four NGOs that filed an October 25, 2012 march-in request for the patents held by Abbott Laboratories/AbbVie relevant to the manufacture and sale of ritonavir, a federally funded invention that is much more expensive in the United States than in Canada, Europe or other high-income countries, and is only available as a co-formulated product with AbbVie’s version of lopinavir. Continue Reading →
Earlier this year, in the case In re K-Dur, the Court of Appeals for the Third Circuit found that reverse settlement agreements, also known as “pay-for delay” arrangements, were prima facie evidence of anticompetitive behavior. The court noted that the presumption that such payments are unreasonable restraints of trade can be rebutted by a showing that the payment either offered a pro-competitive benefit or that the payment was for a purpose other than delayed entry into the market of generics. Continue Reading →
September 10, 2011
KEI Staff
 |
| Christopher Lambert was Deputy Chief of Mission for the United States Embassy in Santo Domingo |
This is a cable written by Christopher Lambert, then the Deputy Chief of Mission for the United States Embassy in Santo Domingo, the capital of the Dominican Republic.
Continue Reading →
Salon has an article today with this title: The seduction of Howard Dean, by Justin Elliot.
Continue Reading →
This was originally published in the Huffington Post here.
————
Continue Reading →
A copy of this document is available here:
http://dsp-psd.pwgsc.gc.ca/Collection-R/LoPBdP/BP/prb9946-e.htm
RB 99-46E
PATENT PROTECTION FOR PHARMACEUTICAL PRODUCTS IN CANADA – CHRONOLOGY OF SIGNIFICANT EVENTS
Prepared by:
Margaret Smith
Law and Government Division
30 March 2000
PATENT PROTECTION FOR PHARMACEUTICAL PRODUCTS IN CANADA – CHRONOLOGY OF SIGNIFICANT EVENTS
Continue Reading →
Draft
This is work in progress, and is part of a larger project on timelines. This particular timeline is unfinished, and may contain errors.
Timeline of privileged regarding the commercialization and use of knowledge
Continue Reading →
Michael Geist has leaked the lasted draft of the intellectual property chapter of the Canada – EU Comprehensive Economic Trade Agreement. These are some brief comments on the new document.
It applies to both parties.
When a very large trading partner negotiates with a smaller one, it is sometimes overlooked that the norms are designed to bind both parties. So the Canada/EU IPR agreement should be of interest to Canada and the 27 members of the European Union.
Continue Reading →